<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03547583</url>
  </required_header>
  <id_info>
    <org_study_id>19334</org_study_id>
    <secondary_id>2018-000298-65</secondary_id>
    <nct_id>NCT03547583</nct_id>
  </id_info>
  <brief_title>Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF</brief_title>
  <acronym>VITALITY-HFpEF</acronym>
  <official_title>A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Trial to Evaluate the Efficacy and Safety of the Oral sGC stImulator Vericiguat to Improve Physical Functioning in Activities of Daily Living in Patients With Heart Failure and Preserved Ejection Fraction (VITALITY-HFpEF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian VIGOUR Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary hypothesis in this trial is that the treatment with vericiguat 10 mg or 15 mg in&#xD;
      patients with HFpEF improves the KCCQ PLS (Kansas City Cardiomyopathy Questionnaire Physical&#xD;
      limitation score) compared to placebo after 24 weeks of treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2018</start_date>
  <completion_date type="Actual">November 4, 2019</completion_date>
  <primary_completion_date type="Actual">October 15, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in KCCQ Physical Limitation Score From Baseline to Week 24</measure>
    <time_frame>From baseline to Week 24</time_frame>
    <description>The City Cardiomyopathy Questionnaire (KCCQ) measures the impact of patients' heart failure, or its treatment, on 6 domains; Physical Limitation, Symptom (with subscores for frequency and burden), Quality of Life, Social Limitations, Symptom Stability and Self-Efficacy. Scores are calculated by summing domain responses and then transforming scores to a 0-100 unit scale with higher scores indicating better health status.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the Six-minute Walk Test (6MWT) From Baseline to Week 24</measure>
    <time_frame>From baseline to Week 24</time_frame>
    <description>6MWT was conducted to test the physical limitations of the patient by assessing the patient's exercise capacity. The distance walked by the patient in 6 minutes was measured.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants With Treatment Emergent Adverse Events</measure>
    <time_frame>From first application of study drug up to 5 calendar days after end of treatment with study drug</time_frame>
    <description>An AE is any untoward medical occurrence (i.e. any unfavorable and unintended sign [including abnormal laboratory findings], symptom or disease) in a patient or clinical investigation patient after providing written informed consent for participation in the study. Adverse events are considered to be treatment-emergent if they have started or worsened after first application of study medication up to 5 calendar days after end of treatment with study medication.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">789</enrollment>
  <condition>Chronic Heart Failure With Preserved Ejection Fraction</condition>
  <arm_group>
    <arm_group_label>Vericiguat up to 10 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, with sham titration at week 6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vericiguat up to 15 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, and to 15 mg at week 6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subject will receive placebo for 24 weeks, once daily, starting sham up-titration at weeks 2, 4, and 6.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tablets</intervention_name>
    <description>Oral use. Vericiguat, which will be started at 2.5 mg at randomization and up-titrated to 5 mg at week 2, and to 10 mg at week 4, with sham titration or up-titration to 15 mg at week 6.</description>
    <arm_group_label>Vericiguat up to 10 mg</arm_group_label>
    <arm_group_label>Vericiguat up to 15 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo and sham up-titration at weeks 2, 4, and 6</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Previous diagnosis of chronic heart failure (HF)&#xD;
&#xD;
          -  HF decompensation within 6 months prior to randomization, defined as hospitalization&#xD;
             for HF or intravenous (IV) diuretic treatment for HF without hospitalization.&#xD;
&#xD;
          -  N-terminal pro brain natriuretic peptide (NT-proBNP) ≥300 or brain natriuretic peptide&#xD;
             (BNP) ≥100 pg/mL in sinus rhythm, or NT-proBNP&#xD;
&#xD;
             ≥600 or BNP ≥200 pg/mL in atrial fibrillation within 30 days prior to randomization&#xD;
&#xD;
          -  Diagnostic criteria of HFpEF by echocardiography assessed within 12 months prior to&#xD;
             randomization (most recent measurement must be used to determine eligibility with no&#xD;
             interim event signaling potential deterioration in ejection fraction)&#xD;
&#xD;
               -  Left ventricular ejection fraction (LVEF) ≥45% and&#xD;
&#xD;
               -  Structural changes indicated by at least one of the following parameters:&#xD;
&#xD;
                    -  Left ventricle (LV) hypertrophy (any of the following: intraventricular&#xD;
                       septal or posterior wall thickness ≥1.1 cm, and/or LV mass index ≥115 g/m*2&#xD;
                       in male and ≥95 g/m*2 in female), or&#xD;
&#xD;
                    -  Left atrium (LA) enlargement (any of the following: left atrial volume (LAV)&#xD;
                       index ≥29 ml/m*2, or LAV &gt;58 mL in male and &gt;52 mL in female patients, or LA&#xD;
                       area &gt;20 cm*2, or LA diameter &gt;40 mm in male and &gt;38 mm in female patients)&#xD;
&#xD;
          -  NYHA class II or III at randomization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical instability at randomization, defined by&#xD;
&#xD;
               -  Any IV treatment within 24h prior to randomization, and/or&#xD;
&#xD;
               -  SBP ≥160 mmHg&#xD;
&#xD;
               -  SBP &lt;110 mmHg and/or DBP &lt;40 mmHg and/or symptomatic hypotension&#xD;
&#xD;
               -  Resting heart rate (HR) &lt;50 or ≥100 beats per minute (bpm)&#xD;
&#xD;
          -  Use of IV inotropes at any time between qualifying HF event and randomization&#xD;
&#xD;
          -  Previous diagnosis of reduced ejection fraction (EF) (EF &lt;40%)&#xD;
&#xD;
          -  Hypertrophic obstructive cardiomyopathy, acute myocarditis, amyloidosis, sarcoidosis,&#xD;
             or pericardial disease&#xD;
&#xD;
          -  Primary valvular heart disease requiring surgery or intervention, or within 3 months&#xD;
             after valvular surgery or intervention, or active endocarditis&#xD;
&#xD;
          -  Acute coronary syndrome, including unstable angina, Non ST-elevation myocardial&#xD;
             infarction or ST-elevation myocardial infarction, or Coronary artery bypass grafting&#xD;
             (CABG) within 60 days prior to randomization, or indication for Percutaneous coronary&#xD;
             intervention or CABG at the time of randomization&#xD;
&#xD;
          -  Symptomatic carotid stenosis, or transient ischemic attack or stroke within 60 days&#xD;
             prior to randomization&#xD;
&#xD;
          -  Complex congenital heart disease&#xD;
&#xD;
          -  Non-cardiac comorbidity (any of the following)&#xD;
&#xD;
               -  Estimated glomerular filtration rate (eGFR) &lt;30 ml/min/1.73 m*2 calculated by&#xD;
                  Modification of Diet in Renal Disease formula&#xD;
&#xD;
               -  Hepatic insufficiency classified as Child-Pugh B or C&#xD;
&#xD;
               -  Morbid obesity with a body mass index &gt;45 kg/m*2&#xD;
&#xD;
               -  Malignancy or other non-cardiac condition limiting life expectancy to &lt;1 year,&#xD;
                  per physician judgment&#xD;
&#xD;
               -  Requires continuous home oxygen for severe pulmonary disease or has interstitial&#xD;
                  lung disease&#xD;
&#xD;
               -  Patients with allergies, intolerance or hypersensitivity to investigational drug&#xD;
                  or any of the excipients&#xD;
&#xD;
          -  Concurrent or anticipated use of nitrates or NO donors, phosphodiesterase type V&#xD;
             (PDE5) inhibitors, or a Soluble guanylate cyclase (sGC) stimulator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>WestSide Medical</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capitol Interventional Cardiology</name>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <zip>95608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Interventional Cardiology Medical Group</name>
      <address>
        <city>West Hills</city>
        <state>California</state>
        <zip>91307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penrose-St. Francis Health Services</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80923</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Fairfield County, PC</name>
      <address>
        <city>Trumbull</city>
        <state>Connecticut</state>
        <zip>06611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates Of South Florida PA</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33472</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular and Vein Center of Florida</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates Research Company</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LifeSpring Research Foundation, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Florida Research</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Coast Institute for Research, LLC</name>
      <address>
        <city>Saint Augustine</city>
        <state>Florida</state>
        <zip>32086</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Partners</name>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <zip>33449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fox Valley Clinical Research Center, LLC</name>
      <address>
        <city>Aurora</city>
        <state>Illinois</state>
        <zip>60506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocate Condell Medical Center</name>
      <address>
        <city>Libertyville</city>
        <state>Illinois</state>
        <zip>60048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reid Health</name>
      <address>
        <city>Richmond</city>
        <state>Indiana</state>
        <zip>47374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Integrity, LLC</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Clinic of Hammond</name>
      <address>
        <city>Hammond</city>
        <state>Louisiana</state>
        <zip>70403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anne Arundel Health System</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riser Medical Associates</name>
      <address>
        <city>Picayune</city>
        <state>Mississippi</state>
        <zip>39466</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis Heart &amp; Vascular, PC</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glacier View Research Institute</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bryan Heart</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Area Research, LLC</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Heart Specialists</name>
      <address>
        <city>Lancaster</city>
        <state>South Carolina</state>
        <zip>29720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stern Cardiovascular Center</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Advancement Center, PLLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78212-4740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Corporation Lane Research Center</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica DIM</name>
      <address>
        <city>Ramos Mejía</city>
        <state>Buenos Aires</state>
        <zip>B1740ETD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Investigaciones Clínicas San Nicolás</name>
      <address>
        <city>San Nicolás</city>
        <state>Buenos Aires</state>
        <zip>B2900DMH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Investigaciones Clínicas</name>
      <address>
        <city>Buenos Aires</city>
        <state>Ciudad Auton. De Buenos Aires</state>
        <zip>C1425DES</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Medicina Integral e Investigacion Clínica</name>
      <address>
        <city>Caba</city>
        <state>Ciudad Auton. De Buenos Aires</state>
        <zip>C1426EGR</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Especialidades Médicas</name>
      <address>
        <city>Villa Luro</city>
        <state>Ciudad Auton. De Buenos Aires</state>
        <zip>C1440CFD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanatorio Parque S.A.</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000DSV</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inst. de Cardiología de Corrientes Juana Francisca Cabral</name>
      <address>
        <city>Corrientes</city>
        <zip>3400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Investigaciones Clinicas del Litoral</name>
      <address>
        <city>Santa Fe</city>
        <zip>S3000FWO</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum St. Pölten</name>
      <address>
        <city>St. Pölten</city>
        <state>Niederösterreich</state>
        <zip>3100</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus St. Josef Braunau</name>
      <address>
        <city>Braunau</city>
        <state>Oberösterreich</state>
        <zip>5280</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordensklinikum Linz GmbH Elisabethinen</name>
      <address>
        <city>Linz</city>
        <state>Oberösterreich</state>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Universität Graz</name>
      <address>
        <city>Graz</city>
        <state>Steiermark</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum f. klinische Studien Dr. Hanusch GmbH</name>
      <address>
        <city>Wien</city>
        <zip>1060</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum AKH Wien</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik Floridsdorf - Krankenhaus Nord</name>
      <address>
        <city>Wien</city>
        <zip>1210</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Algemeen Stedelijk Ziekenhuis Campus Aalst</name>
      <address>
        <city>Aalst</city>
        <zip>9300</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ St-Jan Brugge Oostende AV</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Antwerpen</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Hartziekenhuis Mol</name>
      <address>
        <city>MOL</city>
        <zip>2400</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Delta</name>
      <address>
        <city>Roeselare</city>
        <zip>8800</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment Pazardzhik</name>
      <address>
        <city>Pazardzhik</city>
        <zip>4400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik</name>
      <address>
        <city>Pernik</city>
        <zip>2300</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital for Actrive Treatm of Card - Pleven</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment Medline Clinic</name>
      <address>
        <city>Plovdiv</city>
        <zip>4000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHAT Dr. Bratan Shukerov AD</name>
      <address>
        <city>Smolyan</city>
        <zip>4700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Second Medical Center Sofia EOOD</name>
      <address>
        <city>Sofia</city>
        <zip>1202</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NMTH Tzar Boris III</name>
      <address>
        <city>Sofia</city>
        <zip>1233</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>V MHAT</name>
      <address>
        <city>Sofia</city>
        <zip>1233</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHAT Sveta Marina EAD</name>
      <address>
        <city>Varna</city>
        <zip>9010</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SMH Cardiology Clinical Trials Inc</name>
      <address>
        <city>Surrey</city>
        <state>British Columbia</state>
        <zip>V3V 0C6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PACE Cardiology Clinic</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 2P6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oakville Cardiologists, Inc.</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6K 3W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular CRO Ltd.</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3E 5M4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital Health Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Sante Cardio MC</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 3Y7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre De Recherche Du (CRCHUM) - Hotel-Diu</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 3H8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVasc HR, Inc.</name>
      <address>
        <city>Saint-Jean-sur-Richelieu</city>
        <state>Quebec</state>
        <zip>J3A 1J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General de Medellin</name>
      <address>
        <city>Medellin</city>
        <state>Antioquia</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IPS Centro Cientifico Asistencial S.A.S</name>
      <address>
        <city>Barranquilla</city>
        <state>Atlántico</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caja de Compensación Familiar CAFAM</name>
      <address>
        <city>Bogotá</city>
        <state>Distrito Capital De Bogotá</state>
        <zip>0</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mediservis del Tolima IPS S.A.S</name>
      <address>
        <city>Ibague</city>
        <state>Tolima</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundación Cardiovascular de Colombia</name>
      <address>
        <city>Floridablanca</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität Würzburg</name>
      <address>
        <city>Würzburg</city>
        <state>Bayern</state>
        <zip>97078</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum für Klinische Studien Südbrandenburg GmbH</name>
      <address>
        <city>Elsterwerda</city>
        <state>Brandenburg</state>
        <zip>04910</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum Nordrhein-Westfalen (HDZ NRW)</name>
      <address>
        <city>Bad Oeynhausen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniken Maria Hilf GmbH</name>
      <address>
        <city>Mönchengladbach</city>
        <state>Nordrhein-Westfalen</state>
        <zip>41063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincenz und Elisabeth Hospital, Kathol. Klinikum Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rheinland-Pfalz</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinische Forschung Dresden GmbH</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01069</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiologicum Hamburg - Praxen Wandsbek</name>
      <address>
        <city>Hamburg</city>
        <zip>22041</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KAT General Hospital of Athens</name>
      <address>
        <city>Kifisia / Athens</city>
        <state>Attica</state>
        <zip>14561</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G. GENNIMATAS General State Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Larissa</name>
      <address>
        <city>Larissa</city>
        <zip>41100</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Konstantopoulio General Hospital of Nea Ionia - AGIA OLGA</name>
      <address>
        <city>Nea Ionia / Athens</city>
        <zip>142 33</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;AHEPA&quot; University General Hospital of Thessaloniki</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54636</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hippokration General Hospital of Thessaloniki</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54642</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Budai Irgalmasrendi Korhaz</name>
      <address>
        <city>Budapest</city>
        <zip>1027</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Magyar Honvedseg Egeszsegugyi Kozpont Honvedkorhaz</name>
      <address>
        <city>Budapest</city>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Magyar Honvedseg Egeszsegugyi Kozpont Honvedkorhaz</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pharma4Trial Kft.</name>
      <address>
        <city>Gyongyos</city>
        <zip>3200</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kanizsai Dorottya Hospital</name>
      <address>
        <city>Nagykanizsa</city>
        <zip>8800</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medifarma-98 Egeszsegugyi, Kereskedelmi es Szolgaltato Kft.</name>
      <address>
        <city>Nyiregyhaza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HaEmek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>1834111</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>3810101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rambam Health Corporation</name>
      <address>
        <city>Haifa</city>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Hebrew University Hospital Ein Kerem</name>
      <address>
        <city>Jerusalem</city>
        <zip>9112001</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>5262000</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rehovot</city>
        <zip>7610001</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Baruch Padeh Medical Center, Poria</name>
      <address>
        <city>Tiberias</city>
        <zip>1528001</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Corporation of the Ziv Medical Center (R.A.)</name>
      <address>
        <city>Zefat</city>
        <zip>1311001</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shamir Medical Center (Assaf Harofeh)</name>
      <address>
        <city>Zrifin</city>
        <zip>7030000</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. di Bologna Policlinico S.Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <state>Emilia-Romagna</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. di Ferrara</name>
      <address>
        <city>Ferrara</city>
        <state>Emilia-Romagna</state>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asl Roma 6</name>
      <address>
        <city>Roma</city>
        <state>Lazio</state>
        <zip>00040</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Papa Giovanni XXIII</name>
      <address>
        <city>Bergamo</city>
        <state>Lombardia</state>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <state>Lombardia</state>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Clinico Humanitas - Humanitas Mirasole S.p.A.</name>
      <address>
        <city>Milano</city>
        <state>Lombardia</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Grande Ospedale Metropolitano Niguarda</name>
      <address>
        <city>Milano</city>
        <state>Lombardia</state>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Fondazione Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <state>Lombardia</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. di Sassari</name>
      <address>
        <city>Sassari</city>
        <state>Sardegna</state>
        <zip>07100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seikeikai New Tokyo Heart Clinic</name>
      <address>
        <city>Matsudo</city>
        <state>Chiba</state>
        <zip>271-0077</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Steel Memorial Yawata Hospital</name>
      <address>
        <city>Kitakyushu</city>
        <state>Fukuoka</state>
        <zip>805-8508</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Matsuda Cardiovascular clinic</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>003-0026</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Kobe Medical Center</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>654-0155</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Higashi Takarazuka Satoh Hospital</name>
      <address>
        <city>Takarazuka</city>
        <state>Hyogo</state>
        <zip>665-0873</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Kanazawa Medical Center</name>
      <address>
        <city>Kanazawa</city>
        <state>Ishikawa</state>
        <zip>920-8650</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iwate Prefectural Central Hospital</name>
      <address>
        <city>Morioka</city>
        <state>Iwate</state>
        <zip>020-0066</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uji-Tokushukai Medical Center</name>
      <address>
        <city>Uji</city>
        <state>Kyoto</state>
        <zip>611-0041</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hirakata kohsai Hospital</name>
      <address>
        <city>Hirakata</city>
        <state>Osaka</state>
        <zip>573-0153</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kishiwada Tokushukai Hospital</name>
      <address>
        <city>Kishiwada</city>
        <state>Osaka</state>
        <zip>596-0042</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Takatsuki Red Cross Hospital</name>
      <address>
        <city>Takatsuki</city>
        <state>Osaka</state>
        <zip>569-1096</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka Medical College Hospital</name>
      <address>
        <city>Takatsuki</city>
        <state>Osaka</state>
        <zip>569-8686</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Hamada Medical Center</name>
      <address>
        <city>Hamada</city>
        <state>Shimane</state>
        <zip>697-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minamino Cardiovascular Hospital</name>
      <address>
        <city>Hachioji</city>
        <state>Tokyo</state>
        <zip>192-0918</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toho University Omori Medical Center</name>
      <address>
        <city>Ota-ku</city>
        <state>Tokyo</state>
        <zip>143-8541</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Women's Medical University Hospital</name>
      <address>
        <city>Shinjuku-ku</city>
        <state>Tokyo</state>
        <zip>162-8666</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Iwakuni Clinical Center</name>
      <address>
        <city>Iwakuni</city>
        <state>Yamaguchi</state>
        <zip>740-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fukui Prefectural Hospital</name>
      <address>
        <city>Fukui</city>
        <zip>910-8526</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Okayama Rosai Hospital</name>
      <address>
        <city>Okayama</city>
        <zip>702-8055</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka General Medical Center</name>
      <address>
        <city>Osaka</city>
        <zip>558-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toyama Prefectural Central Hospital</name>
      <address>
        <city>Toyama</city>
        <zip>930-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Raja Perempuan Zainab II</name>
      <address>
        <city>Kelantan</city>
        <zip>15200</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute Jantung Negara</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sarawak Heart Centre</name>
      <address>
        <city>Sarawak</city>
        <zip>94300</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny w Bialymstoku</name>
      <address>
        <city>Bialystok</city>
        <zip>15-276</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>10 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-681</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CLINICAL MEDICAL RESEARCH Sp. z o. o.</name>
      <address>
        <city>Katowice</city>
        <zip>40-156</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SPZOZ Centralny Szpital Kliniczny UM w Lodzi</name>
      <address>
        <city>Lodz</city>
        <zip>92-213</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny Przemienienia Panskiego</name>
      <address>
        <city>Poznan</city>
        <zip>61-848</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Twoja Przychodnia - Szczecinskie Centrum Medyczne</name>
      <address>
        <city>Szczecin</city>
        <zip>70-240</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniwersyteckie Centrum Kliniczne Warszawskiego UM</name>
      <address>
        <city>Warszawa</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IV Wojskowy Szpital Kliniczny z Poliklinika, SPZOZ</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-981</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dolnoslaski Szp. Spec. im T.M. Centrum Medycyny Ratunkowej</name>
      <address>
        <city>Wroclaw</city>
        <zip>54-049</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Cascais</name>
      <address>
        <city>Alcabideche</city>
        <state>Lisboa</state>
        <zip>2755-009</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHTS - Hospital Padre Americo</name>
      <address>
        <city>Guilhufe</city>
        <state>Porto</state>
        <zip>4564-007</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHS - Hospital Sao Bernardo</name>
      <address>
        <city>Setubal</city>
        <state>Setúbal</state>
        <zip>2900-446</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Garcia de Orta</name>
      <address>
        <city>Almada</city>
        <zip>2801-951</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHLO - Hospital Sao Francisco Xavier</name>
      <address>
        <city>Lisboa</city>
        <zip>1449-005</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital da Luz - Lisboa</name>
      <address>
        <city>Lisboa</city>
        <zip>1500-650</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUP - Hospital Santo Antonio</name>
      <address>
        <city>Porto</city>
        <zip>4099-001</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sci-Res. Institute of Complex Cardiovascular Disorders</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research center of therapy and prophylactic medicine</name>
      <address>
        <city>Moscow</city>
        <zip>101990</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moscow State University n.a. M.V. Lomonosov</name>
      <address>
        <city>Moscow</city>
        <zip>119192</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samara Regional Clinical Cardiology Dispensary n.a. Polyakov</name>
      <address>
        <city>Samara</city>
        <zip>443070</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City hospital #15</name>
      <address>
        <city>St. Petersburg</city>
        <zip>198205</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Pokrovskaya Hospital</name>
      <address>
        <city>St. Petersburg</city>
        <zip>199106</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>169608</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Heart Centre Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trial Systems</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durban Medical Centre</name>
      <address>
        <city>Durban</city>
        <state>Kwazulu-Natal</state>
        <zip>4067</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nash Ranjith Research Centre</name>
      <address>
        <city>Merebank</city>
        <state>Kwazulu-Natal</state>
        <zip>4052</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TREAD Research cc</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7500</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tiervlei Trial Centre</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7531</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vergelegen Medi-Clinic</name>
      <address>
        <city>Somerset West</city>
        <state>Western Cape</state>
        <zip>7130</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>A Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ciutat Sanitària i Universitària de Bellvitge</name>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sant Joan Despi Moises Broggi</name>
      <address>
        <city>Sant Joan Despi</city>
        <state>Barcelona</state>
        <zip>08940</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sanitas La Zarzuela</name>
      <address>
        <city>Aravaca</city>
        <state>Madrid</state>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clinica Puerta de Hierro</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Álvaro Cunqueiro</name>
      <address>
        <city>Babio - Beade</city>
        <state>Pontevedra</state>
        <zip>36312</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Ntra. Sra. de Valme</name>
      <address>
        <city>Sevilla</city>
        <zip>41014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Far Eastern Memorial Hospital</name>
      <address>
        <city>New Taipei City</city>
        <zip>220</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>10016</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cheng Hsin General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>112</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Malaysia</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicaltrials.bayer.com/</url>
    <description>Click here to find results for studies related to Bayer products</description>
  </link>
  <link>
    <url>http://www.clinicaltrialsregister.eu/</url>
    <description>Click here to find information about studies related to Bayer Healthcare products conducted in Europe</description>
  </link>
  <reference>
    <citation>Butler J, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O'Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, Wu Y, Carvalho F, Bamber L, Blaustein RO, Roessig L, Armstrong PW. Rationale and Design of the VITALITY-HFpEF Trial. Circ Heart Fail. 2019 May;12(5):e005998. doi: 10.1161/CIRCHEARTFAILURE.119.005998.</citation>
    <PMID>31096775</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 24, 2018</study_first_submitted>
  <study_first_submitted_qc>May 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2018</study_first_posted>
  <results_first_submitted>September 29, 2020</results_first_submitted>
  <results_first_submitted_qc>November 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 3, 2020</results_first_posted>
  <last_update_submitted>December 15, 2020</last_update_submitted>
  <last_update_submitted_qc>December 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/83/NCT03547583/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 21, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/83/NCT03547583/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study was conducted at 178 study centers worldwide, between 15-Jun-2018 (first subject first visit) and 04-Nov-2019 (last subject last visit).</recruitment_details>
      <pre_assignment_details>Overall, 979 participants were screened, of whom 789 participants were randomized in the study. 788 of the randomized participants were allocated to study treatment, of whom 672 participants completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Vericiguat up to 10 mg</title>
          <description>Participants received vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, with sham titration at week 6.</description>
        </group>
        <group group_id="P2">
          <title>Vericiguat up to 15 mg</title>
          <description>Participants received vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, and to 15 mg at week 6 week.</description>
        </group>
        <group group_id="P3">
          <title>Placebo</title>
          <description>Participants received placebo once daily and sham up-titration at weeks 2, 4, and 6.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="263"/>
                <participants group_id="P2" count="264"/>
                <participants group_id="P3" count="262"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="262"/>
                <participants group_id="P2" count="264"/>
                <participants group_id="P3" count="262"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="218"/>
                <participants group_id="P2" count="224"/>
                <participants group_id="P3" count="230"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="32"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-compliance with study drug</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="19"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All participants randomized were valid for the FAS.</population>
      <group_list>
        <group group_id="B1">
          <title>Vericiguat up to 10 mg</title>
          <description>Participants received vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, with sham titration at week 6.</description>
        </group>
        <group group_id="B2">
          <title>Vericiguat up to 15 mg</title>
          <description>Participants received vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, and to 15 mg at week 6 week.</description>
        </group>
        <group group_id="B3">
          <title>Placebo</title>
          <description>Participants received placebo once daily and sham up-titration at weeks 2, 4, and 6.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="263"/>
            <count group_id="B2" value="264"/>
            <count group_id="B3" value="262"/>
            <count group_id="B4" value="789"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="263"/>
                    <count group_id="B2" value="264"/>
                    <count group_id="B3" value="262"/>
                    <count group_id="B4" value="789"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.2" spread="9.7"/>
                    <measurement group_id="B2" value="73.1" spread="9.1"/>
                    <measurement group_id="B3" value="72.8" spread="9.4"/>
                    <measurement group_id="B4" value="72.7" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="263"/>
                    <count group_id="B2" value="264"/>
                    <count group_id="B3" value="262"/>
                    <count group_id="B4" value="789"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="140"/>
                    <measurement group_id="B3" value="121"/>
                    <measurement group_id="B4" value="385"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="139"/>
                    <measurement group_id="B2" value="124"/>
                    <measurement group_id="B3" value="141"/>
                    <measurement group_id="B4" value="404"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="263"/>
                    <count group_id="B2" value="264"/>
                    <count group_id="B3" value="262"/>
                    <count group_id="B4" value="789"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="72"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="235"/>
                    <measurement group_id="B2" value="242"/>
                    <measurement group_id="B3" value="238"/>
                    <measurement group_id="B4" value="715"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="263"/>
                    <count group_id="B2" value="264"/>
                    <count group_id="B3" value="262"/>
                    <count group_id="B4" value="789"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="228"/>
                    <measurement group_id="B2" value="224"/>
                    <measurement group_id="B3" value="222"/>
                    <measurement group_id="B4" value="674"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Six-minute walk test</title>
          <description>Six-minute walk test (6MWT) was conducted to test the physical limitations of the patient by assessing the patient's exercise capacity. The distance walked by the patient in 6 minutes was measured. FAS 6MWT: All patients randomized and treated (at least one dose of the study treatment), and who were able to perform at least one 6MWT assessment at both baseline and post-baseline (excluding safety follow-up).</description>
          <population>The participants in FAS 6MWT were analyzed for this outcome measure.</population>
          <units>Meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="236"/>
                    <count group_id="B2" value="245"/>
                    <count group_id="B3" value="240"/>
                    <count group_id="B4" value="721"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="292.13" spread="107.75"/>
                    <measurement group_id="B2" value="294.99" spread="118.00"/>
                    <measurement group_id="B3" value="295.80" spread="106.27"/>
                    <measurement group_id="B4" value="294.32" spread="110.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Kansas City Cardiopathy Questionnaire Physical limitation score (KCCQ PLS)</title>
          <description>The KCCQ measures the impact of patients' heart failure, or its treatment, on 6 domains; Physical Limitation, Symptom (with subscores for frequency and burden), Quality of Life, Social Limitations, Symptom Stability and Self-Efficacy. Scores are calculated by summing domain responses and then transforming scores to a 0-100 unit scale with higher scores indicating better health status. FAS KCCQ: All patients randomized and treated (at least one dose of the study treatment), and had at least one observed KCCQ PLS assessment at both baseline and during post-baseline (excluding safety follow-up).</description>
          <population>The participants in FAS KCCQ were analyzed for this outcome measure.</population>
          <units>Scores</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="254"/>
                    <count group_id="B2" value="255"/>
                    <count group_id="B3" value="252"/>
                    <count group_id="B4" value="761"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.30" spread="24.77"/>
                    <measurement group_id="B2" value="60.03" spread="24.64"/>
                    <measurement group_id="B3" value="59.03" spread="24.00"/>
                    <measurement group_id="B4" value="58.79" spread="24.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in KCCQ Physical Limitation Score From Baseline to Week 24</title>
        <description>The City Cardiomyopathy Questionnaire (KCCQ) measures the impact of patients' heart failure, or its treatment, on 6 domains; Physical Limitation, Symptom (with subscores for frequency and burden), Quality of Life, Social Limitations, Symptom Stability and Self-Efficacy. Scores are calculated by summing domain responses and then transforming scores to a 0-100 unit scale with higher scores indicating better health status.</description>
        <time_frame>From baseline to Week 24</time_frame>
        <population>FAS KCCQ: All patients randomized and treated (at least one dose of the study treatment), and had at least one observed KCCQ PLS assessment at both baseline and during post-baseline (excluding safety follow-up) were valid for this analysis set.</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat up to 10 mg</title>
            <description>Participants received vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, with sham titration at week 6.</description>
          </group>
          <group group_id="O2">
            <title>Vericiguat up to 15 mg</title>
            <description>Participants received vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, and to 15 mg at week 6 week.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received placebo once daily and sham up-titration at weeks 2, 4, and 6.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in KCCQ Physical Limitation Score From Baseline to Week 24</title>
          <description>The City Cardiomyopathy Questionnaire (KCCQ) measures the impact of patients' heart failure, or its treatment, on 6 domains; Physical Limitation, Symptom (with subscores for frequency and burden), Quality of Life, Social Limitations, Symptom Stability and Self-Efficacy. Scores are calculated by summing domain responses and then transforming scores to a 0-100 unit scale with higher scores indicating better health status.</description>
          <population>FAS KCCQ: All patients randomized and treated (at least one dose of the study treatment), and had at least one observed KCCQ PLS assessment at both baseline and during post-baseline (excluding safety follow-up) were valid for this analysis set.</population>
          <units>Scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="254"/>
                <count group_id="O2" value="255"/>
                <count group_id="O3" value="252"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.41" spread="1.592"/>
                    <measurement group_id="O2" value="5.47" spread="1.538"/>
                    <measurement group_id="O3" value="6.93" spread="1.535"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The analysis of each imputed dataset will be performed using mixed-effects model for repeated measures (MMRM), including treatment, region, heart rhythm, study visit as fixed effects, interaction between study visit and treatment group, and adjustment for the baseline PLS values as covariates.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>= 0.8008</p_value>
            <method>Mixed model repeated-measures</method>
            <param_type>Difference of LS-means</param_type>
            <param_value>-0.52</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.17</ci_lower_limit>
            <ci_upper_limit>4.13</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The analysis of each imputed dataset will be performed using mixed-effects model for repeated measures (MMRM), including treatment, region, heart rhythm, study visit as fixed effects, interaction between study visit and treatment group, and adjustment for the baseline PLS values as covariates.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>= 0.4722</p_value>
            <method>Mixed model repeated-measures</method>
            <param_type>Difference of LS-means</param_type>
            <param_value>-1.46</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.02</ci_lower_limit>
            <ci_upper_limit>3.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Six-minute Walk Test (6MWT) From Baseline to Week 24</title>
        <description>6MWT was conducted to test the physical limitations of the patient by assessing the patient's exercise capacity. The distance walked by the patient in 6 minutes was measured.</description>
        <time_frame>From baseline to Week 24</time_frame>
        <population>FAS 6MWT: All patients randomized and treated (at least one dose of the study treatment), and who were able to perform at least one 6MWT assessment at both baseline and post-baseline (excluding safety follow-up) were valid for this analysis set.</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat up to 10 mg</title>
            <description>Participants will receive vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, with sham titration at week 6.</description>
          </group>
          <group group_id="O2">
            <title>Vericiguat up to 15 mg</title>
            <description>Participants will receive vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, and to 15 mg at week 6 week.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants will receive placebo once daily and sham up-titration at weeks 2, 4, and 6.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Six-minute Walk Test (6MWT) From Baseline to Week 24</title>
          <description>6MWT was conducted to test the physical limitations of the patient by assessing the patient's exercise capacity. The distance walked by the patient in 6 minutes was measured.</description>
          <population>FAS 6MWT: All patients randomized and treated (at least one dose of the study treatment), and who were able to perform at least one 6MWT assessment at both baseline and post-baseline (excluding safety follow-up) were valid for this analysis set.</population>
          <units>Meters</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="236"/>
                <count group_id="O2" value="245"/>
                <count group_id="O3" value="240"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.68" spread="5.841"/>
                    <measurement group_id="O2" value="5.00" spread="5.718"/>
                    <measurement group_id="O3" value="10.49" spread="5.512"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The analysis of each imputed dataset will be performed using mixed-effects model for repeated measures (MMRM), including treatment, region, heart rhythm, study visit as fixed effects, interaction between study visit and treatment group, and adjustment for the baseline 6MWT values as covariates.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>= 0.8054</p_value>
            <method>Mixed model repeated-measures</method>
            <param_type>Difference of LS-means</param_type>
            <param_value>-1.81</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-18.30</ci_lower_limit>
            <ci_upper_limit>14.67</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The analysis of each imputed dataset will be performed using mixed-effects model for repeated measures (MMRM), including treatment, region, heart rhythm, study visit as fixed effects, interaction between study visit and treatment group, and adjustment for the baseline 6MWT values as covariates.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>= 0.4502</p_value>
            <method>mixed model repeated measures</method>
            <param_type>Difference of LS-means</param_type>
            <param_value>-5.49</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-21.77</ci_lower_limit>
            <ci_upper_limit>10.80</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Treatment Emergent Adverse Events</title>
        <description>An AE is any untoward medical occurrence (i.e. any unfavorable and unintended sign [including abnormal laboratory findings], symptom or disease) in a patient or clinical investigation patient after providing written informed consent for participation in the study. Adverse events are considered to be treatment-emergent if they have started or worsened after first application of study medication up to 5 calendar days after end of treatment with study medication.</description>
        <time_frame>From first application of study drug up to 5 calendar days after end of treatment with study drug</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat up to 10 mg</title>
            <description>Participants will receive vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, with sham titration at week 6.</description>
          </group>
          <group group_id="O2">
            <title>Vericiguat up to 15 mg</title>
            <description>Participants will receive vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, and to 15 mg at week 6 week.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants will receive placebo once daily and sham up-titration at weeks 2, 4, and 6.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Treatment Emergent Adverse Events</title>
          <description>An AE is any untoward medical occurrence (i.e. any unfavorable and unintended sign [including abnormal laboratory findings], symptom or disease) in a patient or clinical investigation patient after providing written informed consent for participation in the study. Adverse events are considered to be treatment-emergent if they have started or worsened after first application of study medication up to 5 calendar days after end of treatment with study medication.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="262"/>
                <count group_id="O2" value="264"/>
                <count group_id="O3" value="262"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163"/>
                    <measurement group_id="O2" value="172"/>
                    <measurement group_id="O3" value="172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any study drug related TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="42"/>
                    <measurement group_id="O3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any TESAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="54"/>
                    <measurement group_id="O3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Timeframe for reporting adverse events: From the first application of study medication up to 5 calendar days after end of treatment with study medication. Timeframe for number of death (all causes): After study medication start until last contact date. (The median follow-up time is 197 days.)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Vericiguat up to 10 mg</title>
          <description>Subjects received vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, with sham titration at week 6.</description>
        </group>
        <group group_id="E2">
          <title>Vericiguat up to 15 mg</title>
          <description>Subjects received vericiguat (BAY1021189) for 24 weeks, starting at 2.5 mg once daily at randomization and up-titrated to 5 mg at week 2, to 10 mg at week 4, and to 15 mg at week 6.</description>
        </group>
        <group group_id="E3">
          <title>Placebo</title>
          <description>Subjects received placebo for 24 weeks, once daily, starting sham up-titration at weeks 2, 4, and 6.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (22.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="262"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="264"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="262"/>
                <counts group_id="E2" subjects_affected="54" subjects_at_risk="264"/>
                <counts group_id="E3" subjects_affected="48" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Abdominal incarcerated hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pelvic mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Escherichia pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Medical device site joint infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Scrotal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Vulvovaginal injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Angiocardiogram</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Psoriatic arthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Phaeochromocytoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Thalamus haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Stevens-Johnson syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Leg amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>MedDRA (22.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="121" subjects_at_risk="262"/>
                <counts group_id="E2" subjects_affected="134" subjects_at_risk="264"/>
                <counts group_id="E3" subjects_affected="131" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="262"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="264"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="262"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="264"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="264"/>
                <counts group_id="E3" events="6" subjects_affected="4" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="264"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="262"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="262"/>
                <counts group_id="E2" events="13" subjects_affected="10" subjects_at_risk="264"/>
                <counts group_id="E3" events="10" subjects_affected="8" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="264"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="262"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="264"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="264"/>
                <counts group_id="E3" events="6" subjects_affected="4" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Blood uric acid increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>N-terminal prohormone brain natriuretic peptide increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="264"/>
                <counts group_id="E3" events="13" subjects_affected="12" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="262"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="264"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="264"/>
                <counts group_id="E3" events="10" subjects_affected="8" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="262"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="264"/>
                <counts group_id="E3" events="14" subjects_affected="11" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="264"/>
                <counts group_id="E3" events="16" subjects_affected="11" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="262"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="264"/>
                <counts group_id="E3" events="7" subjects_affected="5" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="9" subjects_affected="7" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="264"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="264"/>
                <counts group_id="E3" events="15" subjects_affected="14" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="264"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="262"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="262"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="264"/>
                <counts group_id="E3" events="8" subjects_affected="6" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="262"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="264"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="262"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="264"/>
                <counts group_id="E3" events="12" subjects_affected="10" subjects_at_risk="262"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="262"/>
                <counts group_id="E2" events="31" subjects_affected="22" subjects_at_risk="264"/>
                <counts group_id="E3" events="14" subjects_affected="12" subjects_at_risk="262"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Therapeutic Area Head</name_or_title>
      <organization>Bayer</organization>
      <phone>(+)1-888-84 22937</phone>
      <email>clinical-trials-contact@bayer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

